State of Alaska Department of Revenue Sells 1,130 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

State of Alaska Department of Revenue lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.7% in the 4th quarter, Holdings Channel reports. The firm owned 40,619 shares of the medical equipment provider’s stock after selling 1,130 shares during the quarter. State of Alaska Department of Revenue’s holdings in Intuitive Surgical were worth $21,201,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in the stock. Berbice Capital Management LLC purchased a new position in Intuitive Surgical during the fourth quarter worth about $26,000. Godsey & Gibb Inc. grew its holdings in shares of Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. bought a new position in shares of Intuitive Surgical in the third quarter worth approximately $33,000. Decker Retirement Planning Inc. bought a new stake in Intuitive Surgical during the fourth quarter valued at approximately $36,000. Finally, Capital Performance Advisors LLP purchased a new position in Intuitive Surgical in the 3rd quarter worth approximately $38,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

ISRG stock opened at $590.90 on Thursday. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The firm has a 50-day moving average of $551.99 and a 200 day moving average of $512.04. The company has a market cap of $210.47 billion, a P/E ratio of 92.18, a PEG ratio of 5.51 and a beta of 1.39.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the stock. Mizuho lifted their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Leerink Partners lifted their price target on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Royal Bank of Canada increased their price objective on Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. UBS Group upped their target price on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research note on Monday, January 27th. Finally, The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a research report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $613.10.

Insider Transactions at Intuitive Surgical

In related news, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares in the company, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the transaction, the chief financial officer now owns 2,630 shares in the company, valued at $1,502,019.30. This represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 28,843 shares of company stock worth $15,357,560 over the last three months. 0.80% of the stock is currently owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.